药物性急性胰腺炎:基于FAERS数据库的真实世界药物警戒研究
本研究基于2004至2022年FAERS数据库中62,206例急性胰腺炎相关不良事件报告,涉及1,175种可疑药物,总结出潜在致急性胰腺炎药物清单及报告数量占比,并通过比例失衡分析检测药物不良反应信号。结果显示二甲双胍报告数最多,降糖药类报告数最多,595种药物显示潜在风险,抗肿瘤药中阳性药物最多。
要点
- 二甲双胍是急性胰腺炎相关报告数最多的药物。
- 降糖药是报告数最多的药物类别,其次为免疫抑制剂等。
- 比例失衡分析显示595种药物具有潜在急性胰腺炎风险信号。
核心结论
- 本研究从药物警戒角度提供了当前全面的急性胰腺炎可疑药物全景,可为临床实践提供参考信息。
研究设计与样本
- 回顾性药物警戒研究,检索FAERS数据库2004至2022年急性胰腺炎相关不良事件报告,共62,206份报告,涉及1,175种可疑药物。
主要发现
- 二甲双胍是急性胰腺炎不良事件报告数最多的药物,其次为喹硫平、利拉鲁肽、艾塞那肽和西格列汀。
- 降糖药是报告数最多的药物类别,其次为免疫抑制剂、精神抑制药、酸相关疾病用药和镇痛药。
- 比例失衡分析中,595种药物显示潜在急性胰腺炎风险,580种药物未显示阳性不良反应信号。
- 按药物类别阳性信号分布,阳性药物数最多的类别是抗肿瘤药。
临床怎么用
- 临床应及时识别并停用可疑药物,这是药物性急性胰腺炎管理的基石。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Timely identification and discontinuation of culprit-drug is the cornerstone of clinical management of drug-induced acute pancreatitis (AP), but the comprehensive landscape of AP culprit-drugs is still lacking. To provide the current overview of AP culprit-drugs to guide clinical practice, we reviewed the adverse event (AE) reports associated with AP in the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database from 2004 to 2022, and summarized a potential AP culprit-drug list and its corresponding AE report quantity proportion. The disproportionality analysis was used to detect adverse drug reaction (ADR) signals for each drug in the drug list, and the ADR signal distribution was integrated to show the risk characteristic of drugs according to the ADR signal detection results. In the FAERS database, a total of 62,206 AE reports were AP-related, in which 1,175 drugs were reported as culprit-drug. On the whole, metformin was the drug with the greatest number of AE reports, followed by quetiapine, liraglutide, exenatide, and sitagliptin. Drugs used in diabetes was the drug class with the greatest number of AE reports, followed by immunosuppressants, psycholeptics, drugs for acid-related disorders, and analgesics. In disproportionality analysis, 595 drugs showed potential AP risk, whereas 580 drugs did not show any positive ADR signal. According to the positive-negative distribution of the ADR signal for drug classes, the drug class with the greatest number of positive drugs was antineoplastic agents. In this study, we provided the current comprehensive landscape of AP culprit-drugs from the pharmacovigilance perspective, which can provide reference information for clinical practice.
引用
- Li D, Wang H, Qin C, et al. Drug-Induced Acute Pancreatitis: A Real-World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database. Clin Pharmacol Ther. 2024. PMID: 38069538. doi:10.1002/cpt.3139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。